They leverage their understanding of both patient inclinations and underlying health concerns to advise which particular GLP-1 receptor agonist would be most effective enhancing overall therapeutic results as well as patient contentment
Laura Nisenbaum, executive director of drug development at the Alzheimers Drug Discovery Foundation, remained optimistic
Nutrient Density Becomes Priority With appetite still suppressed, every calorie needs to earn its place
Many patients who quit tirzepatide early did so because they jumped doses too quickly rather than because the medication itself was unsafe
When they can easily track protein and fluid intake on their Dashboard, along with medication dosing, symptoms, and weight trends, it becomes much easier to communicate with their healthcare team and feel confident they are on track for long-term success," said Sue Heikkinen, MS, RDN, CDCES, BC-ADM, ACE-PT, Lead Dietitian and Clinical Reviewer at MyNetDiary
Diabetes Ther 2014